JENNIFER KRAJEWSKI: Open Payments
NPI 1205436813 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,065 in 53 payments from 9 companies in 2025. Trend: 2023 $1,763 · 2024 $1,231 · 2025 $3,065
Food & beverage: $1,845Consulting: $1,220
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. | 19 | $1,938 |
| TG Therapeutics, Inc. | 19 | $651 |
| Biogen, Inc. | 7 | $235 |
| GENZYME CORPORATION | 2 | $72 |
| ABBVIE INC. | 2 | $44 |
| Genentech, Inc. | 1 | $40 |
| Celgene Corporation | 1 | $33 |
| Amgen Inc. | 1 | $31 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
Products named: Mavenclad, BRIUMVI, TYSABRI, QULIPTA, Ocrevus, ZEPOSIA, UPLIZNA, KESIMPTA.
Industry payments across GA — which companies pay providers there.
